Skip to main content
. 2006 Jul-Aug;17(4):243–250. doi: 10.1155/2006/980328

TABLE 3.

Antimicrobial resistance by year for Shigella (1997 to 2000)

Class and antimicrobial 1997 1998 1999 2000 Total
Resistant, n (%) Tested, n Resistant, n (%) Tested, n Resistant, n (%) Tested, n Resistant, n (%) Tested, n Resistant, n (%) Tested, n
Amphenicols
   Chloramphenicol 38 (18) 211 67 (17) 384 94 (27) 351 63 (22) 281 262 (21) 1227
Aminoglycosides
   Amikacin 0 (0.0) 165 1 (0.45) 223 0 (0.0) 270 1 (0.39) 255 2 (0.22) 913
   Gentamicin 1 (0.38) 262 0 (0.0) 369 3 (0.98) 305 0 (0.0) 339 4 (0.31) 1275
   Netilmicin  –* 0 0 (0.0) 1 0 0 (0.0) 2 0 (0.0) 3
   Streptomycin 0 0 1 (50) 2 190 (75) 252 191 (75) 254
   Tobramycin 0 (0.0) 223 0 (0.0) 368 2 (0.68) 292 3 (1.07) 280 5 (0.43) 1163
Penicillins
  Extended-spectrum penicillins
      Ampicillin 236 (64) 370 424 (79) 539 243 (59) 412 176 (50) 351 1079 (65) 1672
      Carbenicillin 70 (69) 102 92 (78) 118 28 (48) 58 27 (46) 59 217 (64) 337
      Mezlocillin 0 1 (100) 1 0 1 (50) 2 2 (67) 3
      Piperacillin 63 (28) 222 231 (55) 423 112 (32) 351 67 (23) 292 473 (37) 1288
      Ticarcillin 85 (50) 170 201 (72) 278 191 (58) 327 128 (50) 257 605 (59) 1032
Beta-lactam/beta-lactamase inhibitor combinations
   Amoxicillin/K clavulanate 79 (58) 137 221 (68) 324 43 (32) 137 39 (39) 99 382 (55) 697
   Ampicillin/sulbactam 7 (88) 8 1 (100) 1 0 6 (60) 10 14 (74) 19
   Piperacillin/tazobactam 0 0 1 (13) 8 0 (0.0) 116 1 (0.8) 124
   Ticarcillin/K clavulanate 1 (6.7) 15 4 (6.2) 65 2 (3.4) 59 0 (0.0) 6 7 (4.8) 145
Other beta-lactams
   Cephalosporins and related substances
      First generation
         Cefazolin 0 (0.0) 106 2 (1.2) 161 1 (4.2) 24 0 (0.0) 27 3 (0.94) 318
         Cephalothin 76 (26) 287 174 (36) 483 37 (11) 351 34 (10) 339 321 (22) 1460
      Second generation
         Cefamandole 7 (54) 13 5 (31) 16 1 (100) 1 0 13 (43) 30
         Cefotetan 0 0 (0.0) 1 0 0 (0.0) 2 0 (0.0) 3
         Cefoxitin 0 (0.0) 176 0 (0.0) 369 1 (0.35) 289 3 (1.1) 279 4 (0.36) 1113
         Cefuroxime (oral) 0 (0.0) 58 0 (0.0) 32 0 0 (0.0) 2 0 (0.0) 92
         Cefuroxime (parenteral) 0 (0.0) 80 1 (0.63) 160 0 (0.0) 18 0 (0.0) 1 1 (0.39) 259
         Cefonicid 7 (6.9) 102 59 (52) 114 4 (11) 35 0 70 (28) 251
         Loracarbef 0 (0.0) 9 0 0 0 0 (0.0) 9
      Third generation
         Cefoperazone 0 0 (0.0) 1 0 0 (0.0) 2 0 (0.0) 3
         Cefotaxime 0 (0.0) 250 0 (0.0) 354 0 (0.0) 283 0 (0.0) 262 0 (0.0) 1149
         Cefpodoxime 0 0 0 (0.0) 7 0 (0.0) 27 0 (0.0) 34
         Ceftazidime 0 (0.0) 225 0 (0.0) 423 1 (0.28) 352 0 (0.0) 292 1 (0.08) 1292
         Ceftizoxime 0 0 (0.0) 1 0 0 (0.0) 2 0 (0.0) 3
         Ceftriaxone 0 (0.0) 140 1 (0.31) 325 0 (0.0) 136 0 (0.0) 99 1 (0.14) 700
         Cefixime 0 (0.0) 41 0 (0.0) 141 0 (0.0) 51 0 (0.0) 22 0 (0.0) 255
      Fourth generation
         Cefepime 0 0 0 (0.0) 1 0 (0.0) 8 0 (0.0) 9
   Monobactams
      Aztreonam 0 0 (0.0) 1 0 0 (0.0) 10 0 (0.0) 11
   Carbapenems
      Imipenem 0 (0.0) 70 5 (2.4) 211 2 (2.5) 81 0 (0.0) 40 7 (1.7) 402
      Meropenem 0 0 0 0 (0.0) 10 0 (0.0) 10
   Sulfonamides and trimethoprim
      Sulfamethoxazole 21 (95) 22 14 (93) 15 12 (80) 15 174 (69) 252 221 (73) 304
      Trimethoprim 8 (89) 9 1 (100) 1 0 2 (100) 2 11 (92) 12
      Trimethoprim/sulfamethoxazole 255 (69) 368 403 (76) 527 275 (68) 403 211 (62) 345 1144 (70) 1643
Quinolones
   Fluoroquinolones
      Ciprofloxacin 2 (0.59) 341 1 (0.19) 538 4 (0.98) 407 1 (0.29) 350 8 (0.49) 1636
      Levofloxacin 0 0 0 0 (0.0) 10 0 (0.0) 10
      Lomefloxacin 0 (0.0) 9 0 (0.0) 1 0 0 0 (0.0) 10
      Norfloxacin 0 (0.0) 143 0 (0.0) 319 0 (0.0) 134 0 (0.0) 88 0 (0.0) 684
      Trovafloxacin 0 0 0 0 (0.0) 8 0 (0.0) 8
   Other quinolones
      Nalidixic acid 3 (2.7) 113 3 (2.6) 114 2 (5.7) 35 0 8 (3.1) 262
      Ofloxacin 0 (0.0) 9 0 (0.0) 5 0 (0.0) 12 1 (1.7) 59 1 (1.2) 85
   Tetracyclines
      Tetracycline 192 (73) 263 233 (55) 426 271 (78) 346 247 (73) 335 943 (69) 1370
   Other antibacterials
      Nitrofurantoin 2 (1.5) 138 5 (1.8) 275 3 (3.8) 79 3 (3.5) 87 13 (2.3) 579
*

Not tested